MarketScreener Strategies

Sanofi:  Treatment for re-rating isn’t easySanofi: Treatment for re-rating isn’t easy April 07, 2026 at 05:46 pm IST
Sanofi prepares for the future and once again raises its sacrosanct dividendSanofi prepares for the future and once again raises its sacrosanct dividend January 30, 2026 at 05:34 pm IST
Sanofi:  More than operational delivery, markets seek pipeline answersSanofi: More than operational delivery, markets seek pipeline answers January 29, 2026 at 09:41 pm IST
Sanofi reduces valuation after R&D setbacksSanofi reduces valuation after R&D setbacks December 31, 2025 at 11:33 am IST
Trump wants to reduce drug prices by up to 80%Trump wants to reduce drug prices by up to 80% May 12, 2025 at 02:15 pm IST
On the stockmarket, the pharmaceutical industry is wary of FDA's new strongmanOn the stockmarket, the pharmaceutical industry is wary of FDA's new strongman May 07, 2025 at 04:00 pm IST
Sanofi and Novartis are calling for American drug prices in EuropeSanofi and Novartis are calling for American drug prices in Europe April 23, 2025 at 12:56 pm IST
Sanofi :  The Doliprane caseSanofi : The Doliprane case October 18, 2024 at 06:46 pm IST
Sanofi :  reportedly receives two bids of 15 billion for its consumer healthcare unitSanofi : reportedly receives two bids of 15 billion for its consumer healthcare unit September 25, 2024 at 03:06 pm IST
Sanofi :  In the hot seatSanofi : In the hot seat October 30, 2023 at 04:22 pm IST
Sanofi :  The road to reinventionSanofi : The road to reinvention January 10, 2022 at 04:49 pm IST
Sanofi :  At a crossroadsSanofi : At a crossroads August 07, 2018 at 09:26 pm IST
No results for this search